Transcription of Appendix A: Disease-Specific Chapters
{{id}} {{{paragraph}}}
Infectious Diseases Protocol Appendix A: Disease-Specific Chapters chapter : Meningococcal disease , invasive Revised January 2014 2 Meningococcal disease , invasive Communicable Virulent Health Protection and Promotion Act: Ontario Regulation 558/91 Specification of Communicable Diseases Health Protection and Promotion Act: Ontario Regulation 559/91 Specification of Reportable Diseases Aetiologic Agent Meningococcal disease is caused by Neisseria meningitidis, a Gram-negative, Meningococcal serogroups are classified according to the immunological reactivity of the capsular Serogroup A, B, C, Y and W-135 are most commonly associated with invasive meningococcal disease (IMD).
Infectious Diseases Protocol Appendix A: Disease-Specific Chapters Chapter: Meningococcal disease, invasive Revised January 2014
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Canadian Standards of Practice for Case, Standards, Case Management, Management, STANDARDS FOR SOCIAL WORK RECORDING, Practice, Canadian Guidelines for the Management, Canadian Guidelines for the Management of Plaque Psoriasis: Overview, Canadian, Auditing the Treasury Function, Canadian Practical Nurse Registration Examination